Document is current
Any future updates will be listed below
-
Authors
Wuopio, Jonas
Yi-Ting, Lin
Dekkers, Koen F.
Fall, Tove
Smith, J. Gustav
Larsson, Anders
Engström, Gunnar
Orho-Melander, Marju
Johnson, Linda S.
Ärnlöv, Johan
-
Funding
Funding for this research was provided by:
Karolinska Institute
- License Information
-
More Information
Article History
Received: 28 March 2025
Accepted: 16 August 2025
First Online: 2 September 2025
Declarations
:
: The SCAPIS-multicenter study was approved by the ethical review board at Umeå University, Sweden (number 2010-228-31 M) and the add on collection of urine was approved by the ethical board at Uppsala University and Lund University, Sweden (number EPN Uppsala University 2016/387 and 2018/315; Lund University 2016/1031).
: Professor Johan Ärnlöv declares that he has received lecturing fees from AstraZeneca and Boehringer Ingelheim and has served on advisory boards for AstraZeneca and Boehringer Ingelheim and Astella unrelated to the present study. Linda Johnson has received consulting fees from MEDICALgorithmics, Warsaw, and speaker fees from BMS/Pfizer paid to Lund University. None of the other authors have any conflicts of interest to declare.
